Literature DB >> 11114308

Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor.

A E Brinson1, T K Harden.   

Abstract

Agonist-promoted regulation of the uridine nucleotide-activated human P2Y4 receptor (P2Y4-R) and P2Y6 receptor (P2Y6-R) was studied. Incubation of P2Y4-R-expressing 1321N1 human astrocytoma cells with the cognate agonist UTP resulted in rapid desensitization of the inositol phosphate response and a 50% loss of cell surface receptors. In contrast, incubation of P2Y6-R-expressing cells with the cognate agonist UDP caused neither rapid desensitization nor rapid loss of cell surface receptors. Removal of UTP from the medium of UTP-pretreated cells resulted in rapid and complete recovery of surface P2Y4-R even after 12 h of agonist treatment. Although extended incubation with UDP also caused a loss of surface P2Y6-R, rapid recovery of surface P2Y6-R did not occur following removal of agonist. Pharmacological studies indicated that neither protein kinase C nor other Ca(2+)-activated kinases were involved in agonist-promoted desensitization or loss of surface P2Y4-R or P2Y6-R. Mutational analyses were carried out to identify domains involved in agonist-dependent regulation of P2Y4-R. Sequential truncation of the carboxyl-terminal domain revealed that sequence between amino acids 332 and 343 was necessary for UTP-promoted desensitization and internalization. Further mutational analyses of the three serines in this domain confirmed that Ser-333 and Ser-334 play a major role in these agonist-promoted changes in P2Y4-R. Experiments were carried out with [(32)P]P(i)-labeled cells to ascertain the role of phosphorylation in regulation of P2Y4-R. Incubation with UTP for 2 min caused a marked increase in phosphorylation of both the wild-type P2Y4-R and the P2Y4-343 truncation mutant. In contrast, no UTP-promoted phosphorylation of the P2Y4-332 truncation mutant was observed. Taken together, these results demonstrate differential regulation of uridine nucleotide-activated P2Y4-R and P2Y6-R and indicate that Ser-333 and Ser-334 in the carboxyl terminus of P2Y4-R are important for UTP-dependent phosphorylation, desensitization, and loss of surface receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114308     DOI: 10.1074/jbc.M009909200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

2.  Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.

Authors:  Hariharan Subramanian; Kshitij Gupta; Qiang Guo; Ryan Price; Hydar Ali
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

3.  ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells.

Authors:  Edward C Y Wang; Jey-Myung Lee; Wily G Ruiz; Elena M Balestreire; Maximilian von Bodungen; Stacey Barrick; Debra A Cockayne; Lori A Birder; Gerard Apodaca
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2.

Authors:  Carsten Hoffmann; Nicole Ziegler; Susanne Reiner; Cornelius Krasel; Martin J Lohse
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

6.  K+ secretion activated by luminal P2Y2 and P2Y4 receptors in mouse colon.

Authors:  J E Matos; B Robaye; J M Boeynaems; R Beauwens; J Leipziger
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

7.  Modeling species-specific diacylglycerol dynamics in the RAW 264.7 macrophage.

Authors:  Hannah L Callender; Mary Ann Horn; Dianne L DeCamp; Paul C Sternweis; H Alex Brown
Journal:  J Theor Biol       Date:  2009-10-31       Impact factor: 2.691

Review 8.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

9.  Apical targeting of the P2Y(4) receptor is directed by hydrophobic and basic residues in the cytoplasmic tail.

Authors:  D Ross DuBose; Samuel C Wolff; Ai-Dong Qi; Izabela Naruszewicz; Robert A Nicholas
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-10       Impact factor: 4.249

Review 10.  A critical look at the function of the P2Y11 receptor.

Authors:  Karin Dreisig; Birgitte Rahbek Kornum
Journal:  Purinergic Signal       Date:  2016-05-31       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.